Analysis of EGFr, VEGF and p53 in serum of head and neck squamous cell cancer (HNSCC) : Preliminary results of the GORTEC 99-02 randomized trial.

Metges, J.; Grégoire, Vincent; Guenet, D.; Auperin, A.; Maingon, P.; Lesaunier, J.; Calais, G.; Zelek, L.; Bourhis, J.

Analysis of EGFr, VEGF and p53 in serum of head and neck squamous cell cancer (HNSCC) : Preliminary results of the GORTEC 99-02 randomized trial.

Metges, J.

;

Grégoire, Vincent

;

Guenet, D.

;

Auperin, A.

;

Bourhis, J.

;et.al.

(2006) 42nd Annual Meeting of the American-Society-of-Clinical-Oncology — Location: Atlanta (Ga) (2.June.2006)

Files

No attached file found for this publication.

Details

Authors

Metges, J.
Author
Grégoire, VincentUCLouvain
Author
Guenet, D.
Author
Auperin, A.
Author
Bourhis, J.
Author

Affiliations

UCLouvainCliniques universitaires Saint-Luc
UCLouvain

Citations

APA
Chicago
FWB

Metges, J., Grégoire, V., Guenet, D., Auperin, A., Maingon, P., Lesaunier, J., Calais, G., Zelek, L., & Bourhis, J. (2006). Analysis of EGFr, VEGF and p53 in serum of head and neck squamous cell cancer (HNSCC) : Preliminary results of the GORTEC 99-02 randomized trial. Journal of Clinical Oncology, 24(18), 282S-282S. https://hdl.handle.net/2078.5/75410 (Original work published 2006)